In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GE'S Perception of Convergence

Executive Summary

Although much smaller in scale, General Electric Co.'s $9.4 billion acquisition of Amersham PLC (now GE Healthcare's division GE Healthcare Bio-Sciences Inc.) [See Deal] early last year is every bit as radical in its space as Johnson & Johnson's $25.4 billion acquisition of Guidant Corp. is in the cardiovascular world. [See Deal] And while J&J's move highlights the decades-long consolidation movement in major medical device sectors, GE's actions illustrate another key trend: convergence. The Amersham purchase puts GE for first time in the life sciences industry and has a systems-oriented, engineering company talking about intangible, biology-focused strategies like personalized medicine.
Advertisement

Related Content

GE Grabs the Spotlight in IVD
GE's Pharma Ambitions Lead to a Lilly Deal
GE's Pharma Ambitions Lead to a Lilly Deal
The Uterine Fibroid Market: High Growth for Uterus-Sparing Procedures
The Uterine Fibroid Market: High Growth for Uterus-Sparing Procedures
GE's Personalized Play for Amersham
GE's Personalized Play for Amersham
Amersham's Push for High-Value Diagnostics
Amersham's Push for High-Value Diagnostics

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV002446

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel